Dr. Kelly Tappenden interviews Drs. Felix Harpain, Lukas Schlager, and Christopher Dawoud of the Department of General Surgery of the Medical University of Vienna, discussing the integrating SBS-IF patients treated with teduglutide in a proactive and tight-meshed patient care program significantly improves the clinical outcome, leading to an increased proportion of patients reaching enteral autonomy.

The text included in the description of the podcast

Business Corporate by Alex Menco | alexmenco.net

Music promoted by www.free-stock-music.com

Creative Commons Attribution 3.0 Unported License

creativecommons.org/licenses/by/3.0/deed.en_US

February 2022